Purpose: Benign prostatic hyperplasia (BPH) is a histologic diagnosis describing
proliferation of smooth muscle and epithelial cells within the prostatic transition zone. The …

New minimally invasive techniques that reduce morbidity while improving lower urinary tract
symptoms (LUTS) due to benign prostatic hypertrophy (BPH) have become attractive …

Importance There is evidence that 5α-reductase inhibitors (5-ARIs), a standard treatment of
benign prostate hyperplasia, are associated with a decrease in the incidence of prostate …

Myofibroblast buildup and prostatic fibrosis play a crucial role in the development of benign
prostatic hyperplasia (BPH). Treatments specifically targeting myofibroblasts could be a …

BACKGROUND/OBJECTIVES To estimate associations between lower urinary tract
symptoms (LUTS) and phenotypic frailty in older men. DESIGN Cross‐sectional study …

The urinary tract is highly innervated by autonomic nerves which are essential in urinary
tract development, the production of growth factors, and the control of homeostasis. These …

Finasteride and dutasteride, synthetic 5α-reductase inhibitors (5ARIs) are recommended in
many guidelines for the treatment of benign prostatic hyperplasia/lower urinary tract …

Importance Benign prostatic hyperplasia (BPH) in older men can cause lower urinary tract
symptoms (LUTS), which are increasingly managed with medications. Frailty may contribute …

Background: Androgenetic alopecia (AGA) is a common skin disease characterized by
gradually miniaturized hair follicles, which manifests as progressive hair thinning and …

Background: World population is aging. The number of individuals aged over 65 are
expected to be 71 million only in the US. 43% of this population will be men. Benign …